UK-headquartered pharmaceutical company GSK has announced plans to spend $1.2bn on manufacturing facilities and digital technology in the US. The investment includes building a biologics flex factory powered by AI…

Belgian pharmaceutical company UCB says it plans to invest $5bn in a US factory to avoid President Trump’s tariffs on the EU. It makes drugs to treat diseases of the…

The Danish pharmaceutical company behind obesity drug Wegovy, Novo Nordisk, plans to invest US$1.09bn in expanding its facility in Minas Gerais, southeast Brazil. The 74,000-sq-m project will be used for…

Novo Nordisk, the Danish company that makes diabetes drug Ozempic and obesity treatment Wegovy, has begun work on a 5.3ha quality control centre in Hillerød, about 20km north of Copenhagen.…

French drugmaker Sanofi has confirmed its plan to spend €1.3bn on an insulin factory at its site near Frankfurt, website BioProcess International reports. The 36,000-sq-m plant will replace a previous…

Danish drugmaker Novo Nordisk, the firm behind the highly sought-after diabetes treatment Ozempic and obesity treatment Wegovy, will spend $4.1bn on a new factory in North Carolina. The 1.4 million-sq-ft…